Drugs for Neglected Diseases initiative (DNDi)
About Drugs for Neglected Diseases initiative
In 2003, seven organisations from around the world joined forces to establish DNDi: five public sector institutions the Oswaldo Cruz Foundation from Brazil, the Indian Council for Medical Research, the Kenya Medical Research Institute, the Ministry of Health of Malaysia and Frances Pasteur Institute; one humanitarian organisation, Médecins sans Frontières (MSF); and one international research organisation, the UNDP/World Bank/WHOs Special Programme for Research and Training in Tropical Diseases (TDR), which acts as a permanent observer to the initiative. Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for malaria, visceral leishmaniasis (VL), sleeping sickness (human African trypanosomiasis, HAT), and Chagas disease.
- Industry : Pharma